| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: cytotoxic ruthenium(II) organometallic agent; structure in first source
Also Known As:| 1. | Tente, R: 1 article (06/2005) |
| 2. | Sadler, P: 1 article (06/2005) |
| 3. | Jodrell, D I: 1 article (06/2005) |
| 4. | Schornagel, Q C: 1 article (06/2005) |
| 5. | Habtemariam, A: 1 article (06/2005) |
| 6. | Macpherson, J S: 1 article (06/2005) |
| 7. | Hayward, R L: 1 article (06/2005) |
| 8. | Aird, R E: 1 article (06/2005) |
| 9. | Guichard, S: 1 article (06/2005) |
| 1. | Colorectal Neoplasms (Colorectal Cancer)
06/01/2005
- "Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175."
06/01/2005 - "Using isogenic derivatives of the HCT116 colorectal cancer cell line, we investigated the role of p53, p21/WAF1 and Bax in the cellular response to the novel ruthenium(II) organometallic complex RM175, [(eta(6)-C(6)H(5)C(6)H(5))RuCl (H(2)NCH(2)CH(2)NH(2)-N,N')](+) PF(6)(-)" Get all the results and reference details, order at left... |
| 1 Diseases and 1 more articles analyzed in the Research Interface, order at left... | |
| 1. | RM175
|
| 2. | Ruthenium
|
| 2 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left... | |
| Price: | $490.00 access via web interface, 1 year subscription |
| Price: | $45.00 access via "curehunter.com/m", 1 year subscription |